The enrichment of deletions in tumor suppressor loci involved in cell adhesion and EMT regulation further supports the hypothesis that SSTR2 expression is not merely a biomarker but may reflect or contribute to a genetically and phenotypically aggressive subtype of HCC. Here, SSTR2 is linked to neoplasm.